Navigation Links
Insulin Lispro - Comprehensive Patent Search
Date:8/23/2011

NEW YORK, Aug. 23, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Insulin Lispro - Comprehensive patent search

http://www.reportlinker.com/p0447411/Insulin-Lispro---Comprehensive-patent-search.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication

Eliminate unnecessary risk with the industry benchmark in comprehensive patent information.

Pipeline Developer is a regularly updated, professional patent search performed by our expert team, which not only identifies relevant patents, but delivers categorisation and interpretation, all delivered by a convenient online interface.

The Pipeline Developer report covers Insulin Lispro

Insulin Lispro indications: Treatment of diabetes mellitus, optionally in combination with a longer-acting insulin for type 1 diabetes or in a combination therapy with a sulfonylurea agent for type 2 diabetes

Insulin Lispro innovator: Eli Lilly (Humalog, Humalog Kwikpen, Humalog Mix 25, Humalog Mix25 Pen, Humalog Mix 50, Humalog Pen)

Imagine having your own team of pharmaceutical patent experts, at a fraction of the cost and without the wait.

Used by the worlds leading generic pharmaceutical companies and legal teams, Pipeline Developer minimises the risk of wasted developments or legal action, by providing you with nothing less than the very best in comprehensive patent information. Searched and analysed by highly trained, dedicated staff using sophisticated searching techniques, Pipeline Developer delivers results you can rely on. And that means your staff can concentrate on how the patent landscape affects your business, rather than trying to source reliable patent information.

Pipeline Developer features:

# Comprehensive patent searching, covering the world's key territories (see 'search coverage' below)

# Identifies patents covering molecule, formulation, process, use, combination and assay techniques (see 'Patent Categories Identified'below)

# Patent identification, categorisation and interpretation

# Grouped by patent family and assigned to development categories based on Interpretation of key aspects of the patent claims

# Manual filtration of patents not relevant to generic development

# Updated on a monthly basis, including changes to patent families, statuses, and litigation

# Enables fast analysis and verification by hyper-linking to crucial patent documents and national registers

Patent Categories Identified:

1. Molecular Form

a) Molecule Patents

b) Salts, Hydrates & Solvates

c) Polymorphic Forms

d) Other Molecular Forms

2. Active Ingredient Preparation

a) Intermediates & Preparation Thereof

b) Final Synthetic Stages

c) Complete Synthesis

d) Purification Methods

e) Fermentation Methods

f) Biotechnology

3. Formulations & Methods Thereof

a) General Formulations & Methods

b) Injectable Formulations

c) Oral Formulations

d) Other Administration-Specific Formulations

e) Excipients, Kits & Packaging

4. Related Medical Use & Administration

a) New Use Related to Main Indication

b) Dosing Regimen/Administration Conditions

5. Active Ingredient Combinations

a) Novel Combinations

b) Use of Combinations

c) Dosing Regimen & Administration Conditions for Combinations

6. Analytical Methods

a) Assaying Methods

b) Methods of Determining Patient Suitability

Search coverage:

Clicking on a patent family displays detailed information on the 'Core' and 'Non-Core' 'Patent Family Equivalents'. 'Core Patent Family Equivalents' are equivalent patents from territories that are individually verified and monitored for changes, including British, German, Spanish, French, US, Canadian, Australian, European, and PCT patents. Statuses are also monitored and updated. 'Extended Patent Family Equivalents' are equivalent patents found through the INPADOC database, increasing the search coverage to 70 countries.

Patent and national register access:

Clicking on a listed patent/application number or text or image link will launch a pop-up window containing an image of the patent, enabling easy analysis of the patent documents. Clicking on a register link launches a pop-up window with the patent office register extract for that patent. This allows investigation into the examination status of a pending patent, opposition of a granted patent and/or payment of maintenance fees. Please note that no extra charges apply to accessing or downloading documents of any kind.

Litigation alerts:

Informing you of developments in court, litigation alerts can also be accessed by clicking on the litigation symbol next to the status, with links to judgements where available.

Updating:

To take the time and hassle out of monitoring and updating a large number of patents, all Pipeline Developer reporting is updated on a monthly basis. Convenient change flags identify new patent families, new patent family members, changes in statuses and litigation alerts.

Legal status and transaction history:

You can also find legal status and transaction history for 'Extended Patent Family Equivalents' by clicking on the INPADOC Family/Legal Status button for 65 additional territories.

Reporting and access:

All data can be exported into Microsoft Excel and print friendly versions for ease of data manipulation and reporting. Company details are confidential and all data is SSL secure. Five users per company are permitted and access levels are controlled by a nominated 'company administrator'.

Pipeline Developer is just one of the benchmark products from GenericsWeb's Pipeline Patent Intelligence product suite.

Eliminate unnecessary risk with the industry benchmark in comprehensive patent information.

Imagine having your own team of pharmaceutical patent experts, at a fraction of the cost and without the wait. Used by the world's leading generic pharmaceutical companies and legal teams, Pipeline Developer minimises the risk of wasted developments or legal action, by providing you with nothing less than the very best in comprehensive patent information. Searched and analysed by highly trained, dedicated staff using sophisticated searching techniques, Pipeline Developer delivers results you can rely on. And that means your staff can concentrate on how the patent landscape affects your business, rather than trying to source reliable patent information.

To order this report:

Drug and Medication Industry: Insulin Lispro - Comprehensive patent search

Drug and Medication Business News

More  Industry Analysis and Insights

CONTACT
Nicolas Bombourg
Reportlinker
Email: nbo@reportlinker.com
US: (805)652-2626
Intl: +1 805-652-2626


'/>"/>
SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Insulin- Western Europe
2. Insulin- Global
3. Insulin- Eastern Europe
4. Halozymes Ultrafast Insulin Demonstrates Reduced Variability of Insulin Absorption for Type 1 Diabetes Patients Using Insulin Pumps
5. Analysis Compares Cost-Effectiveness of Premixed Insulin Analogs to Long-Acting Insulin Analogs in the Long-Term Treatment of Type 2 Diabetes in the U.S.
6. FDA Approves Updates to Lillys Humalog® (insulin lispro injection [rDNA origin]) Label
7. Asante Solutions Receives FDA Clearance for Pearl™ Insulin Pump
8. Independent Investigator Initiates Phase 1 Study of Biodels Ultra-Rapid-Acting Insulin Formulations in Patients Using Insulin Pumps
9. Asante Solutions, Inc. Receives CE Mark for Pearl™ Insulin Pump
10. Reportlinker Adds Insulin Lispro - Comprehensive Patent Search
11. Biodel Announces Accelerated Development Plan for Ultra-Rapid-Acting Insulins: Initiate Phase 2 in 2011; Phase 3 Pivotal Trials in 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... STUTTGART, Germany , March 27, 2017 /PRNewswire/ ... provide over 7,000 attendees and more than 600 ... learn, and discover opportunities and solutions that will ... - 6 April 2017 at the Messe Stuttgart, ... is the preeminent medical technology platform showcasing the ...
(Date:3/27/2017)... British Columbia, March 27, 2017  Sophiris Bio ... or "Sophiris"), a clinical late-stage biopharmaceutical company developing ... urological diseases, today reported fourth quarter and full ... Key Corporate Highlights: ... Localized Prostate Cancer. During 2016, the Company reported ...
(Date:3/27/2017)... 27, 2017 /PRNewswire/ - INVICTUS MD STRATEGIES CORP. ("Invictus ... Invictus MD is pleased to announce it has received ... on the TSX Venture Exchange.  Receiving ... year of significant achievements for Invictus-MD. Some of which ... at AB Laboratories Inc. ("AB Labs"), a Licensed Producer ...
Breaking Medicine Technology:
(Date:3/28/2017)... ... March 28, 2017 , ... Columbus OH. Dr. Justin Harper, Founder ... few medical professionals in the country to sit on the 2017 National Advisory Board ... just 2 years Dr. Harper helped propel the clinic from a small start-up to ...
(Date:3/28/2017)... , ... March 28, 2017 , ... Public relations pros ... across a variety of business channels. , While many results are clear, much of ... relations program. , When it comes to measurement, firms should always take an ...
(Date:3/28/2017)... ... , ... Oily skin is a common and unwelcomed occurrence in people of all ages, genders ... offer to the discussion of dealing with excess skin oil. “Oily skin is a challenge ... that can help remove the oily shine while keeping the skin fresh and clean,” says ...
(Date:3/28/2017)... California (PRWEB) , ... March 28, 2017 , ... Bacteria and fungi are probably not ... microorganisms are bad. In fact, including the right microorganisms in your diet can actually improve ... favorite foods. , This is the topic of a new peer-reviewed paper ...
(Date:3/27/2017)... ... 2017 , ... New patients who want to experience the benefits of ... them placed by Dr. Manju Kejriwal, with or without a referral. Dr. Kejriwal is ... accuracy of each dental implant placement. The i-CAT CBCT system captures the shapes of ...
Breaking Medicine News(10 mins):